Introduction
The CDKN2A/INK4a/MTS1 tumour suppressor gene on human chromosome 9p21 is a frequent target of inactivating mutations in both sporadic and familial cancers (reviewed in Ruas and Peters, 1998) . For example, the gene sustains homozygous deletions in 40 ± 60% of bladder cancers, gliomas and T-cell acute lymphoblastic leukaemias (T-ALL), is silenced by hypermethylation of the promoter region in colon, breast and non-small cell lung cancers (NSCLC), and sustains missense and nonsense mutations in a signi®cant proportion of biliary tract, pancreatic and oesophageal cancers (Ruas and Peters, 1998) . Over 140 single amino acid changes have already been noted in human tumour cells, aecting 95 of the 156 residues in the protein. Germline mutations are associated with inherited prediposition to melanoma and other cancers (Ruas and Peters, 1998) and since it is estimated that approximately 10% of all melanomas have a familial component and as many as half of the familial cases may harbour CDKN2A mutations, a proper understanding of the impact of these mutations is desirable (Dracopoli and Fountain, 1996; Hayward, 1996) .
The major challenge is to distinguish between innocuous polymorphisms and real germline mutations that impair the function of CDKN2A to dierent degrees. Moreover, since the sporadic mutations described thus far have invariably been found by analysing tumour cells, those regarded as polymorphisms, because of their presence in adjacent unaected tissue, could represent rare germline variants that predispose to cancer. Conversely, it is possible that the sequence variants of CDKN2A recorded in sporadic tumours may re¯ect a mutator phenotype caused by a lesion in DNA repair or`caretaker' genes (Kinzler and Vogelstein, 1997) , and may not necessarily aect the function of the protein. The prevalent use of PCR in the analysis of CDKN2A gene sequences also raises the possibility that some recorded mutations are PCR artefacts.
The product of the CDKN2A gene is a 16 kDa protein, p16 INK4a , comprising four ankyrin-type repeat motifs, that binds speci®cally to and blocks the function of the cyclin dependent kinases CDK4 and CDK6 (Serrano et al., 1993) . When associated with Dtype cyclins, CDK4 and CDK6 promote passage through the G1 phase of the cell cycle by contributing to the phosphorylation and functional inactivation of the retinoblastoma gene product, pRb (reviewed in Sherr, 1994; Weinberg, 1995) . Thus, p16 INK4a and other members of the INK4 family (p15 INK4b , p18
INK4c and p19 INK4d ) are all capable of imposing a G1 cell cycle arrest that is dependent on the presence of functional pRb (Sherr and Roberts, 1995; Ruas and Peters, 1998) . All four proteins bind directly to CDK4 and CDK6 in vitro but, despite their biochemical and structural similarities, only p16
INK4a has the credentials of a tumour suppressor. A likely explanation is that p16
INK4a accumulates as cells reach the end of their replicative lifespan (senescence) so that inactivation of p16
INK4a favours the emergence of immortal cell clones (Alcorta et al., 1996; Hara et al., 1996; Loughran et al., 1996; Rezniko et al., 1996; Yeager et al., 1998) .
The known properties of p16 INK4a have been exploited in the development of functional assays, which fall broadly into three types: (i) the ability of p16
INK4a to bind directly to CDK4 and CDK6; (ii) its ability to inhibit the phosphorylation of pRb by cyclin D-CDK complexes; and (iii) its ability to cause cell cycle arrest when ectopically expressed. Only a minority of the known missense variants have been functionally analysed and although the severe loss-offunction mutants are easily detected, a substantial proportion of the variants tested thus far behave ambiguously in dierent assay systems or have given inconsistent results when analysed by dierent laboratories (Koh et al., 1995; Lukas et al., 1995; Ranade et al., 1995; Reymond and Brent, 1995; Shapiro et al., 1995; Wick et al., 1995; Yang et al., 1995; Enders et al., 1996; Lilischkis et al., 1996; Parry and Peters, 1996; Tevelev et al., 1996; Yarbrough et al., 1996; Zhang and Peng, 1996; Arap et al., 1997; Harland et al., 1997; Sun et al., 1997) . There are a number of possible reasons. The ®rst is that any assay that requires the production of recombinant p16
INK4a in bacteria is vulnerable to aggregation of the protein (Boice and Fairman, 1996; Tevelev et al., 1996; Zhang and Peng, 1996) and to variability caused by having to recover the protein from insoluble inclusion bodies. A second point is that any assay conducted in vitro, such as CDK binding or kinase inhibition, may not be a true re¯ection of the in vivo situation. For example, it is now clear that cyclin D-dependent kinase activity is associated with high molecular weight complexes in vivo and that D cyclins are rarely if ever found in simple binary associations with CDK4 or CDK6 (Della Ragione et al., 1996; Mahony et al., 1998; Musgrove et al., 1998; McConnell et al., 1999) . Similarly, although p16 INK4a does participate in binary complexes with CDKs, it does not associate detectably with D cyclins in vivo (Hall et al., 1995; Parry et al., 1995; Guan et al., 1996; McConnell et al., 1999) . This could in part explain why the ability of p16
INK4a to inhibit cyclin-CDK complexes assembled using baculovirus driven expression in insect cells does not give a linear dose response (for example, see Serrano et al., 1993; Koh et al., 1995; Lukas et al., 1995; Ranade et al., 1995; Parry and Peters, 1996) . Finally, virtually all assays based on the ectopic expression of p16
INK4a in eukaryotic cells are vulnerable to variations in the levels of expression achieved. One of the most frequently used is based on the co-transfection of p16
INK4a cDNA with a cell surface marker so that the proportion of transiently transfected cells arrested in G1 can be measured by¯ow cytometry (Koh et al., 1995; Lukas et al., 1995; Parry and Peters, 1996) . Assays of this type do not lend themselves to quantitative appraisal of variants that may be only partially or conditionally impaired.
Because of these problems, we have sought to devise functional tests that are relatively simple to perform and interpret, and that can detect partially as well as fully impaired variants of p16
INK4a
. Here we compare the ecacy of established and novel assays by testing a series of sporadic and familial variants of p16 INK4a , several of which have given ambiguous results in previous studies. Two assays emerge as the most reliable indicators of p16
INK4a function: binding to CDK4 and CDK6 in vitro and measurements of cell proliferation following infection with retroviruses encoding p16
. Our con®dence in these assays is supported by relating the observed properties of each variant to the predicted eects of the amino acid substitution on the threedimensional structure of p16
.
Results

Interaction of p16
INK4a variants with CDKs in vitro
The most direct functional test for INK4 proteins is whether they can bind eciently to CDK4 and CDK6 in a simple in vitro association assay . and the amount of labelled CDK that co-precipitated with p16
INK4a was assessed by SDS ± PAGE (Figure 1 ). In preliminary tests it was con®rmed that the variant p16
INK4a proteins were synthesized and immunoprecipitated with similar eciency (data not shown). INK4a and the co-precipitated CDKs were analysed by SDS ± PAGE in a 12% polyacrylamide gel and visualized by autoradiography. Load shows the direct analysis of the input CDKs translated in vitro and Vector corresponds to a mock binding assay using the empty pRSETA plasmid Under the conditions used, the A20P, D84H, D84N and D84Y variants showed no detectable binding to CDK4 or CDK6, while there was very little residual binding with L16P, P48L, E88K and InsR113 (see Table 1 for a description of these mutants). The remaining variants, N71S, V95A, H98Y, G122S, A127S, A132P, were indistinguishable from wild-type p16
INK4a in their capacity to interact with CDK4 and CDK6. These data are summarized in Table 1 along with corresponding results for three additional variants that were analysed in previous studies. Thus, M53I failed to bind to CDK4 and CDK6 whereas G101W and A118T retained binding Harland et al., 1997) . This meant that around half (8/ 17) of the variants under consideration here appeared functionally normal in the in vitro assay but only A127S was suspected of being a polymorphism (see Ruas and Peters, 1998) . Signi®cantly, three of the variants in this category, N71S, G101W and A118T, segregate with familial melanoma (Hussussian et al., 1994; Kamb et al., 1994; Harland et al., 1997) .
Conditional binding of p16
INK4a variants to CDK4
As we have previously shown that the G101W mutant is temperature sensitive (ts) in a variety of functional tests , it was of interest to establish whether any of the current panel of variants showed a ts phenotype. The variants that retained CDK binding activity, together with wild-type p16
INK4a
and a non-binding control (A20P) were produced as recombinant proteins in bacteria and puri®ed via the His 6 tag. Preliminary titration experiments were carried out to determine the linear range for the quantitative co-precipitation of CDK4. Since p16 INK4a is prone to aggregation, the appropriate amount can vary considerably depending on the quality and age of the protein preparations. As illustrated in Figure 2 , the G101W mutant showed a progressive reduction in CDK binding when the reaction was performed at increasing temperatures whereas wild-type p16
INK4a was largely unaected. In our experience, it is essential to consider the trend across a range of temperatures since even the wild-type protein can occasionally show reduced binding at 408C, as evident here, which can be oset by an increase in non-speci®c background . Thus, although several of the other variants showed some decrease in binding at higher temperatures (see Table 1 ), only N71S and A118T showed a progressive decline in binding as the temperature was increased (Figure 2 ). It should be emphasized that neither of these variants is as convincingly ts as the G101W mutant.
Ectopic expression of p16
INK4a variants in TIG-ER cells
There were still variants that remained indistinguishable from wild-type in the in vitro binding assay. An obvious source of concern was that the interaction Yoshida et al., 1995; Sou®r et al., 1998) (Liu et al., 1995) (Zhang et al., 1994; Liu et al., 1995; Pollock et al., 1995; Platz et al., 1997) (Walker et al., 1995; FitzGerald et al., 1996; Flores et al., 1997; Harland et al., 1997; Sun et al., 1997; Sou®r et al., 1998) (Hussussian et al., 1994) (Hayashi et al., 1994; Komiya et al., 1995; Liu et al., 1995; Tamimiet al., 1996) (Hayashi et al., 1994; Mori et al., 1994; Zhang et al., 1994 ) (Hayashi et al., 1994) (Ohta et al., 1994; Pollock et al., 1995) (Hayashi et al., 1994) (Hussussian et al., 1994; Kamb et al., 1994; Whelan et al., 1995; Sou®r et al., 1998) (Borg et al., 1996; Platz et al., 1997) (Harland et al., 1997) (Yoshida et al., 1995) (Okamoto et al., 1994; Gonzalez-Zulueta et al., 1995; Suzuki et al., 1995) (Hayashi et al., 1994; Marchetti et al., 1997) The variant forms of p16
INK4a are identi®ed by the residue number¯anked by the wild-type and variant amino acids in single letter code. Thus, L16P refers to the substitution of proline for leucine at position 16. In InsR113 an additional arginine codon has been inserted between R112 and L113. The corresponding nucleotide alterations are indicated under Base change. CDK binding refers to the data illustrated in Figure 1 and in references Harland et al., 1997) . Residual CDK4 binding activity at 378C is expressed as a percentage of the binding activity at 308C and was calculated from the data shown in Figure 2 . The values represent the averages from at least three independent experiments. Growth arrest was determined from the proliferation of retrovirally infected TIG-ER cells as described in Figure 5 . + means indistinguishable from wild-type, 7 means indistingushable from the vector only control and + indicates an intermediate eect, ND, not determined. NSCLC, non-small cell lung cancer. HNSCC, head and neck squamous cell carcinoma between individual components in vitro might not accurately re¯ect the in vivo properties of the proteins. To try to address this possibility, we explored alternative assays based on ectopic expression of p16
INK4a sequences in eukaryotic cells. Several procedures have been described that use two types of readout: the ability of p16
INK4a to cause a G1 cell cycle arrest in transfected cells (Koh et al., 1995; Lukas et al., 1995; Shapiro et al., 1995; Parry and Peters, 1996; Arap et al., 1997) and the interaction of p16
INK4a with either endogenous or exogenous CDKs (Reymond and Brent, 1995; Shapiro et al., 1995; Yang et al., 1995; Castellano et al., 1997b) . One example of the latter approach would be the yeast two hybrid system, which has been used to some eect both in the initial identi®cation of p16
INK4a (Serrano et al., 1993) and in the functional evaluation of mutants (Reymond and Brent, 1995; Yang et al., 1995) . However, we elected to base our assays on mammalian cells since they are more likely to re¯ect the environment in which p16 INK4a normally operates.
An inherent problem with such assays is to control for the levels of expression of the dierent variants. To try to circumvent the variability associated with DNA transfection, we used recombinant retroviruses to express the variant p16 INK4a sequences in primary human diploid ®broblasts. Use of a primary cell strain has the attraction that the cell cycle machinery is presumably intact and should not have sustained the alterations necessary to evolve an immortal cell line. Moreover, we recently showed that retroviral delivery of p16
INK4a into human diploid ®broblasts can induce facets of the senescence phenotype, including G1 cell cycle arrest, accumulation of hypophosphorylated pRb and the expression of senescence associated bgalactosidase activity (McConnell et al., 1998) .
The variant p16 INK4a sequences were tagged with two copies of the HA epitope, to allow discrimination between exogenous and endogenous p16 INK4a . Infectious viruses were produced by transient transfection of the BOSC-23 packaging cell line, and the supernatants were added directly to so called TIG-ER cells, the TIG-3 strain of human ®broblasts engineered to express the receptor for ecotropic retroviruses (Serrano et al., 1997; McConnell et al., 1998) . Infection eciencies were between 50 and 80% as judged by the percentage of cells surviving selection in puromycin. The levels of ectopic p16 INK4a RNA expression in the dierent cell pools were compared at 6 days post infection by Northern blot analysis using a probe speci®c for the HA-tag (Figure 3a) . Relative to the signal from g-actin, equivalent amounts of ectopic p16
INK4a expression were achieved (+20%). Similarly, immunoblotting with two dierent monoclonal antibodies against p16
INK4a con®rmed that the cell pools expressed equivalent levels of HA-tagged p16 INK4a ( Figure 3b) . Importantly, the level of HA-tagged p16
INK4a was quite similar to that of the endogenous p16
INK4a expressed in these`middle-aged' ®broblasts (*40 population doublings). With the exception of A20P, all the variant p16
INK4a proteins were expressed at roughly equivalent levels. Note that the levels of A20P protein did not match those of the A20P RNA (compare Figure 3a and b) suggesting that this variant may be intrinsically unstable.
Interaction between exogenous p16
INK4a and endogenous CDKs
The availability of these infected cell pools enabled us to ask whether the variant proteins were capable of interacting with endogenous CDKs in TIG-ER cells. Cell lysates were immunoprecipitated with antibodies against CDK4 and CDK6 and the amounts of coprecipitating p16
INK4a determined by Western blotting. Again, a clear distinction could be drawn between the exogenous HA-tagged variants and the endogenous p16
INK4a
, the latter serving as an internal control. INK4a variants. His 6 -tagged p16 INK4a proteins were expressed in E. coli and puri®ed on nickel-charged Sepharose. 7.5 ng of each preparation was assayed for binding to 35 S-labelled CDK4 at the indicated temperatures. The labelled CDK4 co-precipitating with p16
INK4a was analysed by SDS ± PAGE and visualized by autoradiography (a). The amount of CDK4 in each precipitate was quanti®ed by phosphorimaging and expressed as a percentage of the input CDK4 (b). Note that whereas a single representative assay is shown in (a), the quantitative data in (b) were calculated from triplicate assays
Although there was some variability in the signals, all of the p16
INK4a variants that retained CDK binding in vitro were also able to interact with CDK4 and CDK6 in vivo (Figure 4 ). As expected, the A20P variant was not detected in the CDK4 or CDK6 immunoprecipitates, presumably due to a combination of reduced binding anity and stability. In general, however, variants that failed to bind CDKs in vitro also failed to associate with CDK4 and CDK6 in transfected or infected cells (additional data not shown).
Eects of p16
INK4a variants on TIG-ER cell proliferation
Since the retrovirally infected TIG-ER cells appeared to be expressing equivalent and physiologically relevant levels of p16
INK4a
, we next asked what eects the variants might have on cell behaviour. Wild-type p16
INK4a has been shown to inhibit the phosphorylation of pRb in these cells and to cause a severe growth arrest in a simple proliferation assay (McConnell et al., 1998) . Pools of TIG-ER cells expressing variant p16
INK4a proteins were monitored for a period of 8 days following the initial puromycin selection. Cells infected with the empty vector grew rapidly, increasing 20 ± 25-fold in number (between four and ®ve population doublings) during the course of the experiment whereas cells expressing wild-type p16 INK4a expanded much more slowly, at most increasing around 3 ± 6-fold ( Figure 5 ). In terms of the variant INK4a proteins, three distinct types of behaviour were observed. With variants of p16
INK4a that were unable to bind to CDKs in vitro, such as A20P, cell proliferation was essentially unimpaired. Interestingly, two of the ts mutants, G101W and A118T, also fell into this category (not shown). Among the variants that retained CDK binding, H98Y and A127S caused a severe growth arrest akin to that of wild-type p16
, whereas N71S, G122S and A132P gave intermediate eects on cell proliferation. The results obtained with the other variants in this study are summarized in Table 1 .
Importantly, the same distinctions were manifest when the phosphorylation status of pRb in these cells was monitored by direct immunoblotting (Figure 6 ). As expected, expression of wild-type p16
INK4a caused a dramatic reduction in the proportion of the hyperphosphorylated (upper band) to hypophosphorylated forms of pRb (lower band). There was also an overall decrease in total amount of pRb in the cells (compare lanes 1 and 2 in Figure 6 ). This phenomenon has been observed in previous studies but the underlying mechanism remains obscure (Sandig et al., 1997; Fang et al., 1998; Frizelle et al., 1998; McConnell et al., 1999) . The non-binding mutant A20P caused no discernible change in the pRb pattern (lane 3) whereas the V95A, H98Y and A127S variants were again indistinguishable from wild-type p16
INK4a (lanes 5, 6 and 8). In contrast, the eects observed with the N71S, G122S and A132P variants were less pronounced, with only a partial reduction in the phosphorylation of pRb ( Figure 6, lanes 4, 7 and 9 ).
Discussion
Relative merits of functional assays for p16
INK4a
In this study, we set out to devise a functional assay or set of assays for p16
INK4a that would potentially discriminate between partially impaired variants and innocuous polymorphisms, as well as resolving some of the inconsistencies that occur in the published literature. For these purposes, we analysed a panel of 17 tumour-speci®c variants of p16
INK4a whose background and properties are summarized in Table 1 . After evaluating a number of dierent approaches, including measurements of kinase inhibition in baculovirus based systems, G1 arrest of transfected U20S cells, and protein-protein interactions and turnover in transfected COS-1 cells ; and data not shown), we conclude that two assays, in vitro binding to CDK4 and CDK6 and the proliferation of retrovirally infected ®broblasts, provide the most reliable information. Indeed, the cell proliferation assay alone may suce, but since it is more time consuming than in vitro binding, the latter still remains our ®rst line assay of choice. In its simplest form, it avoids the problems associated with protein puri®cation and renaturation but its major weakness is that it can only be reliably interpreted in terms of all or nothing eects and does not give a quantitative readout of binding anity (see Figure 1) . Nevertheless, mutants that fail to bind CDKs in vitro are generally impaired in all other functional tests.
The in vitro assay can also be adapted to identify ts variants but among the variants tested here, only N71S, G101W and A118T were considered to be ts (Figure 2 ). Thus far, ts behaviour appears restricted to germline variants associated with familial melanoma, although we have not conducted a systematic search. Since the assay requires the production and careful titration of recombinant protein, it has proved to be rather temperamental and we would not recommend its general application unless improved expression systems can be developed to produce soluble and correctly folded p16
INK4a fusion proteins. We currently place more faith in the impaired function of these variants in the cell proliferation assay (Table 1) .
Given the vagaries of the dierent assay systems and the inconsistencies in the literature, how can we be sure that the cell proliferation assay is more reliable than any of the others? Theoretically, an in vivo assay has variants. Six days after retroviral infection, TIG-ER cells were transferred into 24-well plates and followed for 8 days. The relative numbers of viable cells were determined by staining with crystal violet and measurement of absorbance at 590 nm (Serrano et al., 1997) . Values were normalized against cell number at day 0. Each time point was determined in triplicate and similar results were obtained in at least two independent experiments Correlation of functional data with the structure of p16
One way to judge the reliability of the functional data is to consider the eects that the various sequence alterations might have on the three dimensional structure of the protein. The availability of the crystallographic coordinates for p16 INK4a and related INK4 proteins bound to CDK6 (Brotherton et al., 1998; Russo et al., 1998) 
has enabled us to classify the various p16
INK4a mutants into those aecting buried core residues, surface exposed residues, or residues located in the INK4-CDK interface. As previously discussed (McDonald and Peters, 1998), p16 INK4a belongs to the ankyrin superfamily whose members typically contain multiple (at least four) copies of the so-called ankyrin repeat (Luh et al., 1997; Byeon et al., 1998; Venkataramani et al., 1998) . Each repeat unit comprises a helix ± loop ± helix motif¯anked by b strands and the units are linked together by b hairpins formed by strands from adjacent repeats. The result is an asymmetric structure resembling an extended`L' shape and having only a limited hydrophobic core (see Figure 7) . The convex face of the INK4 protein binds some distance from the active site of the CDK such that the b hairpins lie across the top of the CDK Nterminal lobe with the base of the a helical region making contacts with the C-terminal lobe (Brotherton et al., 1998; Russo et al., 1998) .
The most straightforward variants to interpret are those aecting core amino acids, de®ned here as residues whose side chains are 57% accessible. For example, both L16 and A20 of helix 1 are conserved in all INK4 proteins and are buried within the molecule where they contribute to the hydrophobic core and ensure a close packing of adjacent helices. Replacing either residue with proline would introduce a kink in the helix, by disrupting its mainchain hydrogen bonds and thereby perturbing helical packing. A reciprocal change occurs in the case of P48L. Residue P48 in p16
INK4a is replaced by alanine in the three other INK4 proteins and lies at the beginning of a loop region that in the canonical ankyrin repeat would be expected to constitute an a helix. The absence or shortening of helix-3 is characteristic of the INK4 proteins and results in the splaying of the ®nger-like b-turns that link the adjacent repeats. According to the structural data, P48 is buried and there is unlikely to be enough space to accommodate the bulkier leucine sidechain without distorting the adjacent loop region. The predicted eects of these three mutations are therefore entirely consistent with complete loss of function.
A118 is also in the hydrophobic core of the molecule, in helix 7, and the structure suggests that in the A118T variant, there should be sucient space to accommodate the g oxygen of the threonine residue which would form two additional hydrogen bonds to the carbonyl of V115 and amide of E119. This prediction is consistent with the fact that A118T retains some capacity to bind to CDK4 and CDK6 (Harland et al., 1997) but is at odds with the data in Table 1 that show A118T to be functionally impaired in the cell proliferation assay. Since A118T was identi®ed in the germline of a melanoma kindred Figure 7 The ®gure on the left depicts the electrostatic surface of a model of p16
INK4a derived from the crystallographic coordinates of p18
INK4c (McDonald and Peters, 1998; Venkataramani et al., 1998) . Red indicates negative charge and blue positive charge. The CDK-binding interface faces towards the viewer and is centred approximately between M53 and D84 (Brotherton et al., 1998; Russo et al., 1998) . On the right is a worm representation of the p16
INK4a model in the same view. Selected p16
INK4a mutations discussed in the text are highlighted and labelled. The ®gure was drawn using the programme GRASP (Nicholls et al., 1991) Function and structure of p16 mutants M Ruas et al (Harland et al., 1997) and shows ts properties in the CDK binding assay (Figure 2) , there is little doubt that the functional data are correct. The other ts variants identi®ed here, N71S and G101W, can be classi®ed structurally as alterations to non-core residues that are solvent accessible. The most interesting is N71S which occurs in the germline of a melanoma family but was judged to have only low penetrance (Hussussian et al., 1994) . Previous functional assays were equivocal and led to the conclusion that this variant could represent a rare polymorphism (Ranade et al., 1995; Reymond and Brent, 1995) . The p16
INK4a structure shows that N71 does not participate in the CDK interaction but forms two intramolecular hydrogen bonds, one of which is to the main chain amide of R103 and eectively crosslinks two adjacent ankyrin motifs. Substitution with a serine residue would remove this hydrogen bond and could potentially destabilize the protein. Signi®cantly, N71S behaved as if partially impaired in the cell proliferation assay and we would therefore conclude that it is indeed a loss of function mutation. G101, on the other hand, is one of several glycine residues that are critical for the formation of the ankyrin repeat structure since their ability to adopt a positive phi torsion angle is necessary for the sharp turn between adjacent helices. Substitution with any other residue would be energetically unfavourable. The same argument applies to the G122S variant which despite its ability to bind to CDK4 and CDK6 in vitro is clearly functionally compromised ( Figure 5) .
The third structural category comprises residues involved in the INK4-CDK interface, including D84, E88 and M53 (see Figure 7) . Five dierent mutations have been recorded at D84, changing the encoded amino acid to H, N, Y, E or V (Hayashi et al., 1994; Mori et al., 1994; Zhang et al., 1994; Gonzalez-Zulueta et al., 1995; Komiya et al., 1995; Liu et al., 1995; Tamimi et al., 1996; Marchetti et al., 1997; Olshan et al., 1997) and previous functional assays on D84 variants have given inconsistent results (Koh et al., 1995; Enders et al., 1996; Tevelev et al., 1996; Yarbrough et al., 1996) . However, all three of the D84 variants tested here proved to be functionally impaired (Table 1) . D84 forms a salt bridge with R87 and directly contacts CDK6, suggesting that it is critical to maintain the negative charge on the aspartate residue to neutralise the positively charged arginine (Figure 7) . The D84N, D84H and D84Y mutations would eectively remove the negative charge and dramatically alter the electrostatic character of the CDK-binding surface of p16
INK4a
. Conversely, R87P, which is a well documented loss of function mutation associated with familial melanoma (Hussussian et al., 1994; Koh et al., 1995; Ranade et al., 1995; Reymond and Brent, 1995; Lilischkis et al., 1996; Parry and Peters, 1996; Zhang and Peng, 1996) , would also aect the charge distribution of this region of p16
. In contrast, M53 makes multiple Van der Waals contacts which individually are likely to contribute less binding energy than interactions between charged residues. The M53I alteration presumably interferes with these contacts. Interestingly, this variant behaved as only partially impaired in the cell proliferation assay (Table  1) although we previously scored it as non-functional in the in vitro binding assay (Harland et al., 1997) .
The other partially impaired variant, A132P, was included in the study because it maps within the fourth ankyrin repeat and in previous studies, truncation of p16
INK4a at residue 131 yielded contradictory ®ndings (Yang et al., 1995; Lilischkis et al., 1996) , and the closely related p15
INK4b protein terminates at the equivalent of residue 137. With only 3.5 ankyrin repeats, p15
INK4b may comprise the minimum number required for the stability of the structure. In helix 8, the amide of A132 forms a hydrogen bond with the carbonyl of R128 and insertion of a proline would disrupt this helix. It is possible that the loss of this hydrogen bond is enough to adversely aect the stability of the protein although currently available structural information sheds little light on the likely impact of mutations that map close to the carboxy terminus of p16
INK4a (see compilation in Ruas and .
The three remaining variants in the study are also in this indeterminate category in terms of structural considerations and all three behaved as wild-type in the functional assays. A127S was already considered to be a polymorphism because of its presence in unaected tissues (Okamoto et al., 1994; GonzalezZulueta et al., 1995; Suzuki et al., 1995) and from functional data (Koh et al., 1995) . Since A127 is on the surface of the protein, away from the CDK interacting domains, addition of an oxygen atom, as in A127S, would be readily tolerated. Three other variations have been recorded at this residue, A127V , A127E (Konishi et al., 1996) and A127P (Betticher et al., 1997) and the same arguments apply. In the case of V95, which is not conserved in INK4c and INK4d, the structure indicates that it is partly accessible on the surface of the molecule and that substitution with alanine would be unlikely to have an aect. Curiously, V95 occurs in a 20 amino acid synthetic peptide, corresponding to residues 84 ± 103 of p16
, that is capable of binding to and inhibiting the function of CDK4 (FaÊ hraeus et al., 1996) . Substituting V95 with alanine signi®cantly reduced the eectiveness of the peptide (FaÊ hraeus et al., 1996) but this does not appear to be the case in the full length protein. Thus, although this substitution was recorded in a survey of non-small cell lung cancers (Hayashi et al., 1994) , our data suggest that V95A is either a polymorphism or a sequencing error.
Similarly, our functional data imply that H98Y is not a mutant and the same conclusion was drawn recently by Arap et al. in a survey of glioma-associated sequence variants (Arap et al., 1997) . This contrasts with H98P which we and others have shown to be functionally defective (Koh et al., 1995; Parry and Peters, 1996; Zhang and Peng, 1996) . H98 is not strictly conserved among the INK4 proteins, being replaced by V and L in p18 respectively. These residues are generally buried in helix 6 and the structure suggests that insertion of a proline is likely to disrupt the helix. However, insertion of an aromatic side chain, as in H98Y, should have little eect, although the tyrosine may no longer be completely buried. Point mutations are extremely rare in primary gliomas (Ruas and Peters, 1998) and H98Y is one of several that were identi®ed by sequencing individual clones of PCR-products from dierent focal areas . Since none of these variants appear functionally compromised (Arap et al., 1997) , they were most likely generated during the PCR.
In conclusion, therefore, there is good agreement between the behaviour of the p16
INK4a variants in the cell proliferation assay and the likely eects that these changes would have on the structure of the protein.
Alterations aecting core residues are generally associated with complete loss of function, the one exception being a suspected sequencing artefact, whereas alterations to solvent exposed residues or to the CDK interface can have more subtle eects. Despite these correlations, however, structural modelling is likely to remain an adjunct to rather than a substitute for the biological assays since the precise eect of each alteration cannot be determined with any certainty. For example, although the structure has identi®ed residues involved in the CDK interface, their relative contributions in terms of binding energy remain unknown. Predictions from the structure will invariably have to be con®rmed by biological assays and in this regard, we have developed a relatively convenient and reliable test that can discriminate between severely impaired, partially impaired or functionally normal variants of p16
Materials and methods
Cell culture, DNA transfection and retroviral infection
All cell stocks used in this study were maintained at 378C and 5% CO 2 in Dulbecco modi®ed Eagle's medium (DMEM) supplemented with 10% foetal calf serum (FCS). For transient transfections of COS-1 cells, 10 mg of the appropriate plasmid DNA was added to 1610 6 cells using lipofectamine (Gibco ± BRL). TIG-3 human diploid fibroblasts expressing the cell surface receptor for mouse ecotropic retroviruses (TIG-ER cells) were generated as previously described (McConnell et al., 1998) and maintained in medium containing 300 mg/ml G418. To prepare retroviral stocks, 5610 6 BOSC-23 cells (Pear et al., 1993) were plated in a 10 cm dish and transfected the next day with 10 mg of pBABEpuro retroviral vector DNA (Morgenstern and Land, 1990) using standard calcium phosphate precipitation in the presence of 25 mM chloroquine. Transfection was allowed to proceed for 7 ± 8 h and the cells were grown for a further 18 ± 24 h before harvesting the virus. The volume of medium was reduced to 5 ml and the virus suspensions were recovered 24 h later. Cell debris was removed by passage through a 0.45 mm nitrocellulose ®lter.
For retroviral infections, early passage TIG-ER cells (40 ± 42 population doublings) were plated at 2610 6 cells per 75 cm 2¯a sks and incubated overnight. The culture medium was replaced with 5 ml of viral supernatant from the BOSC-23 cells, together with 3 ml of fresh medium and the equivalent of 8 mg/ml polybrene. After 24 h, the medium was replaced and selection in medium containing 2.5 mg/ml puromycin was initiated on day 2 post-infection and continued for a further 4 days.
Construction of vectors encoding mutant forms of p16
INK4a
Selected missense mutations were introduced into the wildtype p16
INK4a cDNA sequence using synthetic oligonucleotides containing the required base substitution and the QuikChange mutagenesis procedure according to the manufacturer's protocols (Stratagene). All the mutations were veri®ed by DNA sequencing. The respective p16 INK4a coding sequences,¯anked by BamHI and EcoRI restriction sites, were then transferred into the pRSET vector (Invitrogen) to facilitate in vitro translation of His 6 -tagged proteins and the production of recombinant proteins in E. coli. The coding sequences were also transferred into the pcDNA3 vector to permit high level expression in COS-1 cells. Finally, the sequences were inserted into the pBABEpuro retrovirus vector (Morgenstern and Land, 1990) to allow infection of primary ®broblasts. Two copies of the HA tag were incorporated at the amino terminus of the wild-type p16
INK4a construct in pBABEpuro by ligating complementary synthetic oligonucleotides: 26HA-FOR 5'-gatctatgctagcatacccgtacgatgttcctgactatgccggctatccctatgacgtcccggactatg-3' 26HA-REV 5'-gatccatagtccgggacgtcatagggatagccggcatagtcaggaacatcgtacgggtatgctagcat-3'. The variant p16
INK4a sequences were subsequently transferred into the retroviral vector as BamHI-EcoRI fragments.
Preparation of recombinant p16 INK4a
The variant forms of p16
INK4a in the pRSETA vector were transfected into the BL21(DE3)pLysS strain of E. coli. and individual colonies tested for production of recombinant protein after addition of IPTG. Typically, 400 ml cultures were used to prepare stocks of p16
INK4a by exploiting the amino terminal His 6 tag. The recombinant protein was recovered from bacterial inclusion bodies by solubilization in 20 mM Tris HCl (pH 8.0), 0.5 M NaCl, 5 mM imidazole, and 6 M urea and puri®ed directly on nickel-charged chelating Sepharose (Pharmacia). Bound proteins were washed and eluted using the same buer containing 50 mM and 1 M imidazole, respectively. Puri®ed proteins were dialysed stepwise against TBS (25 mM Tris HCl, pH 7.6, 140 mM NaCl, 3 mM KCl) containing 3, 2, or 1 M urea, and concentrated by a ®nal dialysis step against TBS containing 50% glycerol. Protein concentrations were determined using the BCA protein assay reagent (Pierce), and the purity of each preparation was assessed by SDS ± PAGE in a 12% polyacrylamide gel and staining with PAGE Blue-83 (Harlow and Lane, 1988) . Typical protein preparations were approximately 95% pure.
In vitro binding assays
Protein-protein interaction assays were performed as previously described , fractionated by SDS ± PAGE and the labelled components were visualized by autoradiography.
Protein analysis
TIG-ER cells expressing HA-tagged p16
INK4a were analysed 6 days after retroviral infection. For immunoprecipitations, 3610 6 cells were plated into 15 cm dishes and lysates were prepared the following day. The cells were washed twice with phosphate buered saline (PBS) and then placed in 2.5 ml of NP40-lysis buer (50 mM Tris HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P40, 2 mg/ml aprotinin, 0.1 mM NaF, 0.1 mM sodium orthovanadate, 100 mg/ml PMSF). Samples containing 0.3 mg of total protein were immunoprecipitated overnight at 48C with 5 ml of the following antibodies: a-CDK4 (Santa Cruz H-22), a-CDK6 (LBO-1, Bates et al., 1994) and a-p16 (DPAR-12, Parry et al., 1995) plus 25 ml of protein A beads (Pierce). The precipitates were washed four times in lysis buer and once in 50 mM Tris HCl (pH 8.0) and resolved by SDS ± PAGE in a 12% polyacrylamide gel (Harlow and Lane, 1988) .
For immunoblotting, the proteins were transferred to Immobilon-P (Millipore) and the membranes were placed in blocking solution (5% milk powder, 0.2% Tween-20 in PBS) for 30 min. Two monoclonal antibodies were used to detect p16: DCS-50, recognizing the carboxy terminal domain (Lukas et al., 1995) and JC8, recognizing an epitope near the amino terminus of the protein (generously provided by J Koh and E Harlow). Membranes were incubated for 1 h at room temperature with the respective tissue culture supernatants diluted 1 : 5 in blocking buer, then thoroughly washed in 0.2% Tween-20 in PBS. Sheep anti-mouse HRP (1/ 2000) was used as secondary antibody (Amersham). Antibody binding was visualized using Amersham ECL reagents.
For the direct immunoblotting of pRb, 10 6 cells were plated in 10 cm dishes and incubated overnight. Cell lysates were prepared using 200 ml of incomplete sample buer (3% SDS, 96 mM Tris HCl pH 6.8) and after protein quantification using the BCA protein assay reagent (Pierce), the samples were diluted 2 : 1 with 28% glycerol, 7% mercaptoethanol, 0.6% bromophenol blue to achieve the equivalent of 16 Laemmli sample buer (Harlow and Lane, 1988) . Samples corresponding to 50 mg of total protein were resolved by SDS ± PAGE in an 8% polyacrylamide gel (Harlow and Lane, 1988 ) and transferred to Immobilon-P membrane (Millipore). The blot was probed as above using a 1 : 1000 dilution of a mouse monoclonal antibody against pRb (G3-245, PharMingen) as the primary antibody.
RNA analysis
Five days after retroviral infection, 10 6 cells TIG-ER cells were plated in 10 cm dishes and incubated overnight. RNA was prepared using the RNeasy kit as recommended by the manufacturer (Qiagen). Samples (15 mg) of total RNA were fractionated by electrophoresis through a 1.2% agarose gel containing 2.2 M formaldehyde and transferred to Hybond N membrane (Amersham). The blots were prehybridized for 1 h at 658C in 66SSPE (16SSPE is 0.18 M NaCl, 10 mM sodium phosphate, pH 7.7, 1 mM EDTA) containing 0.5% SDS and 56Denhardt's reagent (16Denhardt's reagent is 0.02% ®coll, 0.02% polyvinylpyrrolidone and 0.02% BSA). and hybridized overnight with labelled probe. The 26HA-REV oligonucleotide terminally labelled with g-32 P-ATP was used to detect HA-tagged exogenous p16
INK4a transcripts. The blot was washed three times in 16SSPE/0.1% SDS at 658C for 20 min and once in 0.16SSPE/0.1% SDS. Signals were visualized by autoradiography and quanti®ed by phosphorimaging.
Cell proliferation assays
TIG-ER cells were infected with recombinant retroviruses encoding p16 INK4a and 5 days post infection, 5610 3 puromycin resistant cells were plated in 24-well plates. At various times thereafter, individual wells were washed twice with PBS, ®xed in 10% formaldehyde and rinsed twice with water. Cells were stained with 0.1% crystal violet for 30 min and washed four times with water. Intracellular stain was extracted with 1 ml of 10% acetic acid, diluted with an equal volume of water, and the optical density at 590 nm was determined. Values were normalized to that obtained at day 0 for cells expressing each p16
INK4a variant. The day 0 value was determined immediately after cells had adhered to the tissue culture plate (generally 4 ± 5 h after plating). Each time point was assayed in triplicate.
